Structural and Functional Impact of the Human L-FABP T94A Variant on Ligand Binding and Nuclear Signaling

The human liver fatty acid binding protein (L-FABP) is a key intracellular mediator in lipid homeostasis, facilitating the transport of long-chain fatty acids and xenobiotics to nuclear receptors such as PPARα. A common polymorphism in the FABP1 gene—T94A—results in a threonine-to-alanine substitution at position 94 and has been linked to dyslipidemia, non-alcoholic fatty liver disease (NAFLD), and reduced response to fibrate therapy. While previous studies suggested this variant may abolish ligand binding, direct experimental evidence was lacking. This study systematically investigates the structural and functional consequences of the T94A substitution using recombinant proteins and primary human hepatocytes.

Biophysical characterization revealed that the T94A mutation induces significant changes in secondary structure. CD spectroscopy showed increased α-helical content and decreased β-sheet formation in the T94A variant compared to wild-type T94T L-FABP. These alterations were accompanied by a marked reduction in thermal stability, with the melting temperature dropping from 85°C to approximately 65–75°C. The destabilization likely arises from the replacement of a polar, medium-sized threonine with a smaller, nonpolar alanine, disrupting local hydrogen bonding and hydrophobic packing within the protein core.

Despite these structural changes, ligand-binding affinity for physiologically relevant agonists—including phytanic acid, fenofibrate, and fenofibric acid—remained largely unchanged. ANS displacement assays yielded similar Kd values across both variants, confirming that the ligand-binding cavity remains functionally intact. However, the conformational dynamics upon ligand interaction were markedly different. Fenofibric acid, the active metabolite of fenofibrate, induced more substantial structural rearrangements in the T94A variant than in the wild-type protein, suggesting altered allosteric behavior or impaired transition to an active signaling state.

Functional relevance was evaluated in cultured primary human hepatocytes genotyped for the T94T/T94A polymorphism. Cells expressing the T94A variant exhibited significantly reduced induction of PPARα target genes—such as L-FABP, FATP5, and PPARα itself—following fenofibrate treatment. This blunted transcriptional response indicates that while ligands can still bind, the downstream signaling cascade is impaired, likely due to defective structural transitions required for nuclear translocation and coactivator recruitment.Diethyl Formula

These findings demonstrate that the T94A variant is not a null mutation but rather a gain-of-structural perturbation that compromises functional output.γ-Dodecanolactone References The altered conformational landscape disrupts the efficiency of ligand-mediated activation of PPARα, explaining the diminished therapeutic response observed in clinical settings.PMID:35173459 This work underscores the importance of considering protein dynamics beyond static binding affinity when assessing genetic variation in metabolic regulators. It also supports the development of next-generation fibrates designed to effectively engage and activate the structurally compromised T94A variant, paving the way for precision medicine in lipid disorders.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com